The tumor virus landscape of AIDS-related lymphomas

Blood

Volumn 125, Issue 20, 2015, Pages e14-e22

  Arvey, Aaron ^a   Ojesina, Akinyemi I ^b,c   Pedamallu, Chandra Sekhar ^b,c   Ballon, Gianna ^d   Jung, Joonil ^b,c   Duke, Fujiko ^b,c   Leoncini, Lorenzo ^e   De Falco, Giulia ^e   Bressman, Eric ^d   Tam, Wayne ^d   Chadburn, Amy ^f   Meyerson, Matthew ^b,c   Cesarman, Ethel ^d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF SIENA   (Italy)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Heterogeneous viral gene expression suggests that variable host immunosurveillance of ebv latency may influence lymphomagenesis.; Revealing the oncogenic herpesvirus ebv as the sole detected infectious agent.; We evaluated a cohort of arl samples for known and novel tumor viruses

Indexed keywords

VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; COHORT ANALYSIS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; LYMPHOMA; LYMPHOMA CELL; MAJOR CLINICAL STUDY; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS; VIRUS GENE; CLUSTER ANALYSIS; COMPLICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LYMPHOMA, AIDS-RELATED; PATHOLOGY; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

CELL TRANSFORMATION, VIRAL; CLUSTER ANALYSIS; COHORT STUDIES; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; LYMPHOMA, AIDS-RELATED; ONCOGENIC VIRUSES; TUMOR VIRUS INFECTIONS;

EID: 84945466762     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-11-599951     Document Type: Article

References (47)

1. Parkin DM. The global health burden of infectionassociated cancers in the year 2002. Int J Cancer. 2006;118(12):3030-3044.
2. Silverberg MJ, Chao C, Leyden WA, et al. HIV infection and the risk of cancers with and without a known infectious cause. AIDS. 2009;23(17): 2337-2345.
3. Gates AE, Kaplan LD. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology (Williston Park). 2002;16(4):441-451.
4. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007; 370(9581):59-67.
5. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266(5192):1865-1869.
6. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096-1100.
7. Franceschi S, Lise M, Clifford GM, et al; Swiss HIV Cohort Study. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer. 2010; 103(3):416-422.
8. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA, Study HACM; HIV/AIDS Cancer Match Study. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99(12):962-972.
9. d'Arminio Monforte A, Sabin CA, Phillips A, et al; Antiretroviral Therapy Cohort Collaboration. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Arch Intern Med. 2005;165(4):416-423.
10. Ledergerber B, Telenti A, Egger M. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. BMJ. 1999;319(7201):23-24.
11. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virusinfected adults. J Natl Cancer Inst. 2000;92(22): 1823-1830.
12. Simard EP, Engels EA. Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis. 2010;51(8):957-962.
13. Gaidano G, Carbone A, Dalla-Favera R. Genetic basis of acquired immunodeficiency syndromerelated lymphomagenesis. J Natl Cancer Inst Monogr. 1998;(23):95-100.
14. Said J, Cesarman E, Knowles D. Lymphadenopathy and the lymphoid neoplasms associated with HIV infection and other causes of immunosuppression. In: Orazzi AWL, Foucar K, Knowles DM, eds. Knowles' Neoplastic Hematopathology. Baltimore: Wolters Kuwer/ Williams and Wilkins; 2014:584-658.
15. Carbone A. Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol. 2003;4(1):22-29.
16. Cesarman E. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Lett. 2011;305(2):163-174.
17. Patel P, Hanson DL, Sullivan PS, et al; Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008;148(10): 728-736.
18. Swerdlow S, Campo E, Harris N, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
19. Hans CP, Weisenburger DD, Vose JM, et al. A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood. 2003;101(6):2363-2367.
20. Chadburn A, Chiu A, Lee JY, et al. Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol. 2009;27(30):5039-5048.
21. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4): 357-359.
22. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754-1760.
23. Arvey A, Tempera I, Tsai K, et al. An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe. 2012;12(2):233-245.
24. Kostic AD, Ojesina AI, Pedamallu CS, et al. PathSeq: software to identify or discover microbes by deep sequencing of human tissue. Nat Biotechnol. 2011;29(5):393-396.
25. Grabherr MG, Haas BJ, Yassour M, et al. Fulllength transcriptome assembly from RNA-Seq data without a reference genome. Nat Biotechnol. 2011;29(7):644-652.
26. Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22(2):292-298.
27. Strong MJ, Xu G, Morici L, et al. Microbial contamination in next generation sequencing: implications for sequence-based analysis of clinical samples. PLoS Pathog. 2014;10(11): e1004437.
28. Tierney RJ, Shannon-Lowe CD, Fitzsimmons L, Bell AI, Rowe M. Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA. Virology. 2015;474: 117-130.
29. Young L, Alfieri C, Hennessy K, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med. 1989; 321(16):1080-1085.
30. Kersten MJ, Van Gorp J, Pals ST, Boon F, Van Oers MH. Expression of Epstein-Barr virus latent genes and adhesion molecules in AIDS-related non-Hodgkin's lymphomas: correlation with histology and CD4-cell number. Leuk Lymphoma. 1998;30(5-6):515-524.
31. Schmitz R, Young RM, Ceribelli M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012;490(7418):116-120.
32. Xue SA, Labrecque LG, Lu QL, et al. Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi. Int J Cancer. 2002;99(5): 635-643.
33. Bell AI, Groves K, Kelly GL, et al. Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative realtime PCR assays. J Gen Virol. 2006;87(Pt 10): 2885-2890.
34. Trapnell C, Williams BA, Pertea G, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28(5):511-515.
35. Young P, Anderton E, Paschos K, White R, Allday MJ. Epstein-Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and cochaperones. JGen Virol.2008;89(Pt 4): 866-877.
36. Haque T, Chaggar T, Schafers J, Atkinson C, McAulay KA, Crawford DH. Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases. J Med Virol. 2011; 83(2):311-316.
37. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739-1740.
38. Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer. 2010;10(12): 878-889.
39. Ambinder RF. Gammaherpesviruses and "Hit-and-Run" oncogenesis. Am J Pathol. 2000;156(1):1-3.
40. Bechtel D, Kurth J, Unkel C, Küppers R. Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas. Blood. 2005; 106(13):4345-4350.
41. Mancao C, Altmann M, Jungnickel B, Hammerschmidt W. Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus. Blood. 2005;106(13): 4339-4344.
42. Roughan JE, Thorley-Lawson DA. The intersection of Epstein-Barr virus with the germinal center. J Virol. 2009;83(8): 3968-3976.
43. Dittmer DP, Hilscher CJ, Gulley ML, Yang EV, Chen M, Glaser R. Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma. Int J Cancer. 2008;123(9):2105-2112.
44. Razzouk BI, Srinivas S, Sample CE, Singh V, Sixbey JW. Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma. J Infect Dis. 1996;173(3):529-535.
45. Srinivas SK, Sample JT, Sixbey JW. Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line. J Infect Dis. 1998; 177(6):1705-1709.
46. Paiardini M, Müller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev. 2013; 254(1):78-101.
47. Hong JJ, Amancha PK, Rogers K, Ansari AA, Villinger F. Spatial alterations between CD4(1) T follicular helper, B, and CD8(1) T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape. J Immunol. 2012;188(7): 3247-3256.